Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Tranexamic Acid 1000 Mg10 Ml 100 Mgml Intraven Vial Ml

Research Leaders

5 sponsors active, led by Stanford University

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
Phase 4 (1)

Trial Status

Completed5

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT06438185Not ApplicableCompleted

Efficacy And Safety of An IRE System For Treatment of Inferior Turbinate Hypertrophy

NCT06687629Not ApplicableCompleted

Best Practice in the Management of Concha Bullosa in FESS Operation

NCT06812676Not ApplicableCompleted

Virtual Reality Induced Analgesia for Nasal Procedures

NCT06310083Not ApplicableCompletedPrimary

Endoscopic Submucosal Resection Turbinoplasty VS Turbinectomy

NCT04754230Phase 4Completed

Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery

Showing all 5 trials

Research Network

Common Treatments

  • Tranexamic Acid 1000 Mg10 Ml 100 Mgml Intraven Vial Ml1
  • Virtual Reality Goggles1
  • Ire System1
  • Concha Bullosa Crushing1
  • Concha Bullosa Resection1

Active Sponsors

  • Stanford University1
  • Ahmed Nabil Selim1
  • ENTire Medical Ltd.1
  • Helsinki University Central Hospital1
  • King Faisal Specialist Hospital & Research Center1

Top Investigators

Related Conditions

  • Nasal Obstruction2
  • Deviated Nasal Septum Congenital2
  • Deviated Nasal Septum Acquired2
  • Rhinitis1
  • Sinusitis Recurrent1

Activity Timeline